Accord Healthcare, incepted in UK is a fast-growing pharmaceutical company with presence in >85 countries, Accord Healthcare continues to build its presence in APAC region with the office in Singapore, focusing on improving the accessibility of healthcare for patients across the region.
- Booth: D205
ACT Genomics is an innovation-driven cancer solution provider operating around the world. With our NGS technology, CAP-accredited laboratories, experienced bioinformatics team, and proprietary AI algorithms, we “Turn genomics into action”.
- Booth: E313
Agilent, a global leader in analytical and clinical laboratory technologies, provides trusted answers that help scientists and clinicians solve scientific challenges, so they can bring great science to life.
- Booth: A401
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics.
- Booth: E101
Amoy Diagnostics Co., Ltd
Amoy Diagnostics Co., Ltd. is a pioneer and globally leading company in the field of molecular diagnostics for precision oncology, focusing on companion diagnostics product development and commercialization.
- Booth: D116
Astellas Pharma Inc.
Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. Astellas stands on the forefront of healthcare change to turn innovative science into VALUE for patients.
- Booth: B401
AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to deliver life-changing medicines to patients. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.
- Booth: A101
BeiGene Singapore Pte Ltd
BeiGene is a global biotechnology company discovering and developing innovative oncology treatments that are more affordable and accessible to cancer patients worldwide.
- Booth: E201
Burning Rock Dx LLC
Burning Rock Dx (NASDAQ: BNR) is committed to providing NGS-based testing for cancer patients, biomarker detection and companion diagnostic development services to pharmaceutical partners, and NGS-based multi-cancer early detection testing.
- Booth: E305
Canhelp Genomics Co., Ltd.
Canhelp Genomics focuses on molecular diagnostics in oncology. For cancer of unknown primary (CUP), our product Canhelp-OriginTM, which identifies the tissue of tumor origin, is the first and only NMPA and CE approved product of its kind globally.
- Booth: E306
Daiichi Sankyo Co., Ltd.
With more than 120 years of scientific expertise and a presence in nearly 30 countries/regions, Daiichi Sankyo strives to realize 2030 Vision to become an “Innovative Global Healthcare Company Contributing to the Sustainable Development of Society”.
- Booth: D201
Eisai Co., Ltd.
Eisai is known as a global pharmaceutical company based in Japan. The company's business revolves around the research and development, manufacturing and marketing of pharmaceuticals. Eisai is primarily focused on critical medical needs such as neuroscience and cancer therapy.
- Booth: D101
Everest Pharmaceuticals Limited
Everest Pharmaceuticals is one of the most innovative emerging pharmaceutical company in Bangladesh through making precision cancer medicine accessible and affordable to the global cancer patients.
- Booth: A306
Exelixis is an oncology-focused biotechnology company striving to accelerate discovery, development, and commercialization of products for difficult-to-treat cancers through continued evaluation of approved products and expansion of product pipeline.
- Booth: B302
Gene Solutions is a Southeast Asian biotechnology group specializing in cell-free DNA testing, with a background in genetics, cancer biology, and clinical medicine. We strive to improve public health using advanced, high-quality genetic solutions at the most reasonable price.
- Booth: A402
Gilead and Kite Oncology
Gilead and Kite Oncology are creating the future of oncology. From ADCs and small molecules to cell therapy, our R&D programs and partnerships are focused on helping to bring more life to people with cancer and changing the way cancer is treated.
- Booth: D105
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
- Booth: D111
Guardant Health AMEA is a wholly owned subsidiary of Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics.
- Booth: A301
Hetero Labs Ltd.
Hetero is a pharmaceutical player engaged in R&D, manufacturing, and marketing of chemical and biologic drugs across diverse therapeutic areas. It’s strategic business areas include APIs, generics, biosimilars and custom pharmaceutical services.
- Booth: B301
At Illumina, our mission is to improve human health by unlocking the power of the genome. We have developed comprehensive genomic profiling tools that help investigators identify biomarkers, describe tumor biology, and inform therapy selections.
- Booth: D117
Juniper Biologics Pte Ltd
Juniper Biologics is focused on creating access to the next generation of life-changing medicines in Oncology, Rare/Orphan Diseases and Gene Therapy for patient communities in China, Japan, Asia, Australia, New Zealand, the Middle East and Africa.
- Booth: E311
Medpace is a scientifically-driven, global, full service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries.
- Booth: B305
Merck Healthcare KGaA
We are committed to improving the futures of those living with cancer. By maximizing the impact of our standard-of-care treatments and pioneering new medicines, we endeavor to create a world where more cancer patients can become cancer survivors.
- Booth: E301
At MSD, we use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions.
- Booth: A201
Natera is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives.
- Booth: A305
Pfizer Pte Ltd
At Pfizer, we apply science and our global resources to advance wellness, prevention, and treatments, delivering breakthroughs that change patients’ lives. We are committed to support access to reliable, affordable healthcare around the world.
- Booth: B201
Pierre Fabre Singapore Pte. Ltd.
Pierre Fabre is a leading French medical and beauty care company with 4 decades of experience in innovation, development, manufacturing, and commercialization in oncology.
- Booth: D211
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche’s truly differentiated medicines and personalised healthcare strategy aims at enabling tangible improvements in the lives of patients.
- Booth: C101
Seagen is a global biotechnology company that discovers, develops, and commercializes medicines for cancer. The company has a pipeline of therapies at various stages of preclinical testing, clinical testing, and development.
- Booth: B306